LORI FIRESTONE: Open Payments
NPI 1922145283 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,357 in 117 payments from 15 companies in 2025. Trend: 2023 $2,025 · 2024 $1,897 · 2025 $2,357
Food & beverage: $2,357
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $370 |
| Alkermes, Inc. | 13 | $303 |
| Neurocrine BioSciences, Inc. | 11 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $242 |
| ABBVIE INC. | 13 | $207 |
| Vanda Pharmaceuticals Inc. | 13 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $188 |
| Janssen Pharmaceuticals, Inc | 7 | $137 |
| Teva Pharmaceuticals USA, Inc. | 6 | $122 |
| Lundbeck LLC | 5 | $120 |
Products named: REXULTI, LYBALVI, INGREZZA, CAPLYTA, VRAYLAR, FANAPT, TRINTELLIX, SPRAVATO.
Industry payments across TN — which companies pay providers there.
